Bod Science Limited, formerly BOD Australia Limited, is an Australia-based cannabis centric healthcare company. The Company is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia, United Kingdom, Europe and United States, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The Company operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company is developing research and development (R&D) and a defined clinical trial pathway to commercialize and deliver premium, scientifically products for the consumer and medical markets.